Subscribe
Sign In
Tag: CBT > Federal Cannabis Research
Cannabis Industry Research
The Man Behind DEA’s Federal Marijuana Scam
DEA Senior Policy Adviser Matthew Strait defied presidential mandates for medical research, MMJ International Holdings claims.
January 28, 2025
Industry Headlines
Does Medical Cannabis Have Physical, Mental Health Risks? Rutgers Health Kicks Off Study
Rutgers Health researchers will emphasize cannabis use disorder, which involves tolerance and dependence, in the five-year, federally funded study.
December 17, 2024
Industry Headlines
DEA Continues to Block MMJ Marijuana Drug Development for Neurological Disorder
MMJ submitted an FDA Investigational New Drug application for a cannabis-derived medication.
December 11, 2024
Industry Headlines
FDA Clears MAPS Researchers to Proceed With Cannabis Study for Veterans With PTSD
The Multidisciplinary Association for Psychedelic Studies (MAPS) researchers negotiated with the FDA for three years.
November 22, 2024
Cannabis Industry Research
Medical Marijuana Act Signed by Biden Would Hinder Research Under Rescheduling
The Medical Marijuana and Cannabidiol Research Expansion Act’s requirements would remain under Schedule III, a congressional researcher says.
September 20, 2024
Industry Headlines
MMJ BioPharma Suing DEA Over Cannabis Reform, Medical Research
The biopharmaceutical company filed a lawsuit, citing ‘unjustified’ delays in processing an application for medical research.
September 11, 2024
Hemp Regulations in U.S.
US Government Selling Reference Material to Hemp, Cannabis Testing Labs to Ensure Accuracy
The National Institute of Standards and Technology is charging $783 for three 1.5-gram hemp samples to help labs calibrate their methods for accurate labeling.
July 9, 2024
Advocacy for Cannabis Legalization
Senate Democrats Introduce Bill to Federally Legalize Cannabis
The Cannabis Administration and Opportunity Act aims to deschedule marijuana by removing it from the Controlled Substances Act.
May 1, 2024
Legislation and Regulation
Federal Cannabis Legalization and Reform: Where Are We in 2024?
U.S. cannabis reform hasn’t come easy amid a divided Congress, but plenty of opportunities remain on the table for the remainder of the year.
April 20, 2024
Cannabis Rescheduling
Biden’s Failed Actions on Cannabis Issues ‘Borders on Political Malpractice,’ Lawmaker Says
Rep. Earl Blumenauer asked Health Secretary Xavier Becerra to relay his concerns on cannabis reform to the president during a committee hearing.
March 22, 2024
New Mexico
Bright Green Corp. Submits DEA Registration For Production of Schedule I, II Controlled Substances
The application follows the company’s approval from the New Mexico Board of Pharmacy this year.
March 7, 2024
Federal Cannabis Legalization
US Congressman Introduces Bill to Remove Cannabis From CSA, Allow Interstate Commerce, Provide 280E Relief
The legislation has bipartisan support, including from the co-chairs of the Congressional Cannabis Caucus.
December 8, 2023
Page 1 of 2
Next Page